Overview


According to FutureWise analysis the market for sleep disorder in 2023 is US$ 25.25 billion, and is expected to reach US$ 63.51 billion by 2031 at a CAGR of 12.2%.

Sleep disorder, also known as somnipathy, is a medical illness in which the sleep cycle is disrupted. Sleep deprivation has a severe impact on a person's general health and ability to concentrate. It causes fatigue throughout the day. Insomnia can disrupt daily living by affecting reaction time to common stimuli, hand-eye coordination, and memory. Narcolepsy is a sleep condition characterised by uncontrollable sleep for periods of less than a minute or more than an hour. Patients with narcolepsy have also been found to have greater sleep attacks after pregnancy, stress, or illness. This disease can lead to serious health problems like allergies and respiratory disorders, as well as chronic discomfort, nocturia, and tension and worry. Mental, physical, social, and emotional functioning are all affected by this illness. However, patent expirations of important sleep problem therapy medications, as well as adverse effects such restlessness and nausea, are limiting market expansion. The industry is augmented by the expanding use of social media and the growing addiction to electronics such as smartphones and laptops. In addition, the industry is being fueled by an increase in public and private health coverage that includes sleep clinics. In addition, continuous research into the negative consequences of sleep deprivation, as well as the growing use of sleep clinics, are bolstering the market. However, an increase in patent expirations, generic competition, and adverse effects associated with sleep disorder medications may stymie the market in the near future.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Sleep Disorder Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Sleep Disorder Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Astellas Pharma Inc
  • Cadwell Laboratories Inc
  • Cardinal Health
  • Compumedics Limited
  • Eisai Co Ltd
  • Evotec AG
  • Ferring International Center SA
  • GlaxoSmithKline plc
  • Heptares Therapeutics Ltd
  • Koninklijke Philips N.V
  • Natus Medical Incorporated
  • ResMed Inc
  • Somnetics International, Inc
  • Takeda Pharmaceutical Company Limited
  • Teleflex Inc
  • Teva Pharmaceutical Industries Ltd

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Disorder Type

  • Sleep apnea
    • Obstructive sleep apnea
    • Central sleep apnea
    • Complex sleep apnea
  • Insomnia
  • Restless legs syndrome (RLS)
  • Narcolepsy
  • Others

By Product

  • Diagnostics
    • Actigraphy systems
    • Polysomnography (PSG) device
    • Respiratory polygraph
    • Sleep screening devices
    • Home sleep tests
    • Others
  • Therapeutics
    • Cognitive behavioural therapy
    • Therapeutic devices
      • Airway clearance system
      • Adaptive servo-ventilation (ASV)
      • Positive airway pressure (PAP) devices
      • Oral appliances
      • Oxygen devices
      • Others
    • Medication therapy
      • Benzodiazepines
      • Dual orexin receptor antagonists
      • Melatonin receptor agonists
      • Antidepressants
      • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Sleep Disorder Market By Disorder Type, By Product and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Sleep Disorder Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Sleep Disorder Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Sleep Disorder Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Sleep Disorder Market, By Disorder Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Sleep apnea
         1.1. Obstructive sleep apnea
         1.2. Central sleep apnea
         1.3. Complex sleep apnea
        2. Insomnia
        3. Restless legs syndrome (RLS)
        4. Narcolepsy
        5. Others

  • 8.   Sleep Disorder Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostics
         1.1. Actigraphy systems
         1.2. Polysomnography (PSG) device
         1.3. Respiratory polygraph
         1.4. Sleep screening devices
         1.5. Home sleep tests
         1.6. Others
        2. Therapeutics
         2.1. Cognitive behavioral therapy
         2.2. Therapeutic devices
          2.2.1. Airway clearance system
          2.2.2. Adaptive servo-ventilation (ASV)
          2.2.3. Positive airway pressure (PAP) devices
          2.2.4. Oral appliances
          2.2.5. Oxygen devices
          2.2.6. Others
         2.3. Medication therapy
          2.3.1. Benzodiazepines
          2.3.2. Dual orexin receptor antagonists
          2.3.3. Melatonin receptor agonists
          2.3.4. Antidepressants
          2.3.5. Others

  • 9.   North America Sleep Disorder Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Sleep Disorder Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Sleep Disorder Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Sleep Disorder Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Astellas Pharma Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Cadwell Laboratories Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cardinal Health
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Compumedics Limited
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Eisai Co Ltd
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Evotec AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Ferring International Center SA
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. GlaxoSmithKline plc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Heptares Therapeutics Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Koninklijke Philips N.V
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Natus Medical Incorporated
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. ResMed Inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Somnetics International, Inc
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Takeda Pharmaceutical Company Limited
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Teleflex Inc
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Teva Pharmaceutical Industries Ltd
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients